When it comes to NVDA… “acceleration cycles” are the key

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!

Mark Christianson net worth and biography

Mark Christianson Biography and Net Worth

Director of NeuroOne Medical Technologies

In excess of 15 years of executive sales, sales management, marketing, and project management experience with development stage companies. Prior to NeuroOne, Mr. Christianson held the positions of North American Sales Manager for Cortec Corporation, a manufacturer of specialty chemical products, and Regional Sales Manager for PMT Corporation, a leading manufacturer of products for neurosurgery, orthopedics and plastic surgery. He holds an accounting degree from Augsburg College.

What is Mark Christianson's net worth?: The estimated net worth of Mark Christianson is at least $211,326.26 as of June 5th, 2024. Mr. Christianson owns 297,224 shares of NeuroOne Medical Technologies stock worth more than $211,326 as of November 17th. This net worth estimate does not reflect any other assets that Mr. Christianson may own. Additionally, Mr. Christianson receives a salary of $260,850.00 as Director at NeuroOne Medical Technologies. Learn More about Mark Christianson's net worth.
How old is Mark Christianson?: Mr. Christianson is currently 57 years old. There are 3 older executives and no younger executives at NeuroOne Medical Technologies. The oldest executive at NeuroOne Medical Technologies is Mr. Ronald W. McClurg, Chief Financial Officer, who is 64 years old. Learn More on Mark Christianson's age.
What is Mark Christianson's salary?: As the Director of NeuroOne Medical Technologies Co., Mr. Christianson earns $260,850.00 per year. There are 3 executives that earn more than Mr. Christianson. The highest earning executive at NeuroOne Medical Technologies is Mr. David A. Rosa M.D., President, CEO & Director, who commands a salary of $759,980.00 per year. Learn More on Mark Christianson's salary.
How do I contact Mark Christianson?: The corporate mailing address for Mr. Christianson and other NeuroOne Medical Technologies executives is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. NeuroOne Medical Technologies can also be reached via phone at (952) 426-1383 and via email at [email protected]. Learn More on Mark Christianson's contact information.
Has Mark Christianson been buying or selling shares of NeuroOne Medical Technologies?: Mark Christianson has not been actively trading shares of NeuroOne Medical Technologies during the last quarter. Most recently, Mark Christianson sold 25,800 shares of the business's stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $0.88, for a transaction totalling $22,704.00. Following the completion of the sale, the director now directly owns 297,224 shares of the company's stock, valued at $261,557.12. Learn More on Mark Christianson's trading history.
Are insiders buying or selling shares of NeuroOne Medical Technologies?: During the last year, NeuroOne Medical Technologies insiders bought shares 1 times. They purchased a total of 75,000 shares worth more than $105,000.00. During the last year, insiders at the sold shares 3 times. They sold a total of 42,555 shares worth more than $45,818.60. The most recent insider tranaction occured on June, 5th when Director Mark Christianson sold 25,800 shares worth more than $22,704.00. Insiders at NeuroOne Medical Technologies own 7.5% of the company. Learn More about insider trades at NeuroOne Medical Technologies.
Information on this page was last updated on 6/5/2024.

Mark Christianson Insider Trading History at NeuroOne Medical Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/5/2024	Sell	25,800	$0.88	$22,704.00	297,224
12/26/2023	Sell	6,848	$1.35	$9,244.80	332,039
12/21/2023	Sell	9,907	$1.40	$13,869.80	340,687
3/23/2023	Sell	12,711	$1.50	$19,066.50	337,494
3/21/2023	Sell	2,122	$1.60	$3,395.20	361,872
6/23/2021	Sell	11,300	$6.74	$76,162.00	1,077,906

Mark Christianson Buying and Selling Activity at NeuroOne Medical Technologies

NeuroOne Medical Technologies Company Overview

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Today's Range

Now: $0.71

$0.68

$0.78

50 Day Range

MA: $0.92

$0.71

$1.02

2 Week Range

Now: $0.71

$0.60

$2.00

Volume

342,712 shs

Average Volume

97,104 shs

Market Capitalization

$21.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

When it comes to NVDA… “acceleration cycles” are the key

From DTI | Ad